Who Still Gets Ligated? Reasons for Persistence of Surgical Ligation of the Patent Ductus Arteriosus Following Availability of Transcatheter Device Occlusion for Premature Neonates

Overview

Journal J Cardiovasc Dev Dis

Specialty Cardiology & Vascular Diseases

Date 2024 May 24

PMID 38786954

Authors

Julia K Hoffmann

Zahra Khazal

Wievineke Apers

Puneet Sharma

Constance G Weismann

Kira Kaganov

Craig R Wheeler

Michael Farias

Diego Porras

Philip Levy

Sarah U Morton

Affiliations

Soon will be listed here.

Abstract

(1) Background: To identify reasons for the persistence of surgical ligation of the patent ductus arteriosus (PDA) in premature infants after the 2019 Food and Drug Administration (FDA) approval of transcatheter device closure; (2) Methods: We performed a 10-year (2014-2023) single-institution retrospective study of premature infants (<37 weeks) and compared clinical characteristics and neonatal morbidities between neonates that underwent surgical ligation before (epoch 1) and after (epoch 2) FDA approval of transcatheter closure; (3) Results: We identified 120 premature infants that underwent surgical ligation ( = 94 before, = 26 after FDA approval). Unfavorable PDA morphology, active infection, and recent abdominal pathology were the most common reasons for surgical ligation over device occlusion in epoch 2. There were no differences in demographics, age at closure, or outcomes between infants who received surgical ligation in the two epochs; (4) Conclusions: Despite increasing trends for transcatheter PDA closure in premature infants, surgical ligation persists due to unfavorable ductal morphology, active infection, or abdominal pathology.

References

Smith A, McNamara P, El-Khuffash A . Non-pharmacological management of a hemodynamically significant patent ductus arteriosus. Semin Fetal Neonatal Med. 2018; 23(4):245-249. DOI: 10.1016/j.siny.2018.03.008. View

Semberova J, Sirc J, Miletin J, Kucera J, Berka I, Sebkova S . Spontaneous Closure of Patent Ductus Arteriosus in Infants ≤1500 g. Pediatrics. 2017; 140(2). DOI: 10.1542/peds.2016-4258. View

Palmeri N, Kramer D, Karchmer A, Zimetbaum P . A Review of Cardiac Implantable Electronic Device Infections for the Practicing Electrophysiologist. JACC Clin Electrophysiol. 2021; 7(6):811-824. DOI: 10.1016/j.jacep.2021.03.021. View

Pouldar T, Wong R, Almeida-Jones M, Zahn E, Lubin L . Bedside Transcatheter Patent Ductus Arteriosus Device Occlusion in an Extremely Low Birth Weight Neonate: A Novel Approach in a High-Risk Population. Case Rep Anesthesiol. 2021; 2021:4716997. PMC: 8566062. DOI: 10.1155/2021/4716997. View

Kaluarachchi D, Rysavy M, Carper B, Chock V, Laughon M, Backes C . Secular Trends in Patent Ductus Arteriosus Management in Infants Born Preterm in the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr. 2023; 266:113877. PMC: 10922632. DOI: 10.1016/j.jpeds.2023.113877. View

Kuntz M, Staffa S, Graham D, Faraoni D, Levy P, DiNardo J . Trend and Outcomes for Surgical Versus Transcatheter Patent Ductus Arteriosus Closure in Neonates and Infants at US Children's Hospitals. J Am Heart Assoc. 2021; 11(1):e022776. PMC: 9075185. DOI: 10.1161/JAHA.121.022776. View

Nealon E, Rivera B, Cua C, Ball M, Stiver C, Boe B . Follow-up after Percutaneous Patent Ductus Arteriosus Occlusion in Lower Weight Infants. J Pediatr. 2019; 212:144-150.e3. PMC: 6707834. DOI: 10.1016/j.jpeds.2019.05.070. View

Wheeler C, Gagner D, Stephens H, Kraus A, Zurakowski D, Friedman K . Phenotyping respiratory decompensation following definitive closure of the patent ductus arteriosus in preterm infants. J Perinatol. 2021; 42(5):649-654. DOI: 10.1038/s41372-021-01226-z. View

Sathanandam S, Gutfinger D, OBrien L, Forbes T, Gillespie M, Berman D . Amplatzer Piccolo Occluder clinical trial for percutaneous closure of the patent ductus arteriosus in patients ≥700 grams. Catheter Cardiovasc Interv. 2020; 96(6):1266-1276. PMC: 7754477. DOI: 10.1002/ccd.28973. View

10.

Kabra N, Schmidt B, Roberts R, Doyle L, Papile L, Fanaroff A . Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms. J Pediatr. 2007; 150(3):229-34, 234.e1. DOI: 10.1016/j.jpeds.2006.11.039. View

11.

Mitchell C, Rivera B, Cooper J, Smith C, Berman D, Slaughter J . Percutaneous closure of the patent ductus arteriosus: opportunities moving forward. Congenit Heart Dis. 2019; 14(1):95-99. DOI: 10.1111/chd.12704. View

12.

OByrne M, Millenson M, Grady C, Huang J, Bamat N, Munson D . Trends in transcatheter and operative closure of patent ductus arteriosus in neonatal intensive care units: Analysis of data from the Pediatric Health Information Systems Database. Am Heart J. 2019; 217:121-130. PMC: 6861695. DOI: 10.1016/j.ahj.2019.08.009. View

13.

Lai K, Richardson T, Berman D, DeMauro S, King B, Lagatta J . Current Trends in Invasive Closure of Patent Ductus Arteriosus in Very Low Birth Weight Infants in United States Children's Hospitals, 2016-2021. J Pediatr. 2023; 263:113712. DOI: 10.1016/j.jpeds.2023.113712. View

14.

Sathanandam S, Agrawal H, Chilakala S, Johnson J, Allen K, Knott-Craig C . Can transcatheter PDA closure be performed in neonates ≤1000 grams? The Memphis experience. Congenit Heart Dis. 2019; 14(1):79-84. DOI: 10.1111/chd.12700. View

15.

Bixler G, Powers G, Clark R, Walker M, Tolia V . Changes in the Diagnosis and Management of Patent Ductus Arteriosus from 2006 to 2015 in United States Neonatal Intensive Care Units. J Pediatr. 2017; 189:105-112. DOI: 10.1016/j.jpeds.2017.05.024. View

16.

Bischoff A, Kennedy K, Backes C, Sathanandam S, McNamara P . Percutaneous Closure of the Patent Ductus Arteriosus in Infants ≤2 kg: IMPACT Registry Insights. Pediatrics. 2023; 152(3). DOI: 10.1542/peds.2023-061460. View

17.

Wheeler C, Vogel E, Cusano M, Friedman K, Callahan R, Porras D . Definitive Closure of the Patent Ductus Arteriosus in Preterm Infants and Subsequent Short-Term Respiratory Outcomes. Respir Care. 2022; 67(5):594-606. DOI: 10.4187/respcare.09489. View

18.

Weisz D, Giesinger R . Surgical management of a patent ductus arteriosus: Is this still an option?. Semin Fetal Neonatal Med. 2018; 23(4):255-266. DOI: 10.1016/j.siny.2018.03.003. View

19.

Agrawal H, Waller 3rd B, Surendan S, Sathanandam S . New Patent Ductus Arteriosus Closure Devices and Techniques. Interv Cardiol Clin. 2018; 8(1):23-32. DOI: 10.1016/j.iccl.2018.08.004. View

20.

Krichenko A, Benson L, Burrows P, MOES C, McLaughlin P, Freedom R . Angiographic classification of the isolated, persistently patent ductus arteriosus and implications for percutaneous catheter occlusion. Am J Cardiol. 1989; 63(12):877-80. DOI: 10.1016/0002-9149(89)90064-7. View